Get the Stockscreener App
10.85
1.90%
-0.21
Mobia Medical Inc stock is traded at $10.85, with a volume of 38,716.
It is down -1.90% in the last 24 hours and down -16.41% over the past month.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
See More
Previous Close:
$11.06
Open:
$10.8
24h Volume:
38,716
Relative Volume:
0.31
Market Cap:
$360.75M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.70%
1M Performance:
-16.41%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.80
$11.39
1-Week Range:
$10.55
$12.31
52-Week Range:
$10.55
$15.29
Mobia Medical Inc Stock (MOBI) Company Profile
Name
Mobia Medical Inc
Sector
Industry
Phone
(855) 628-9375
Address
2802 FLINTROCK TRACE, SUITE 226, AUSTIN
Compare MOBI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MOBI
Mobia Medical Inc
|
10.85 | 360.75M | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Mobia Medical Inc Stock (MOBI) Latest News
Mobia Medical, Inc. (MOBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Mobia Medical, Inc. (NASDAQ:MOBI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Mobia Medical to report Q2FY26 results on August 11 - scanx.trade
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
Gpg Mti 25, Llc Net Worth (2026) - GuruFocus
Gpg Gr, Llc Net Worth (2026) - GuruFocus
Gpg Healthcare Opportunities Fund, Llc Net Worth (2026) - GuruFocus
Gpg Mti 22, Llc Net Worth (2026) - GuruFocus
Gpg Dais, Llc Net Worth (2026) - GuruFocus
Gpg Charles & Potomac, Llc Net Worth (2026) - GuruFocus
Gpg Mobi, Llc Net Worth (2026) - GuruFocus
Gpg Sc, Llc Net Worth (2026) - GuruFocus
Gpg Wg, Llc Net Worth (2026) - GuruFocus
Gpg Mti 3 17 Investment, Llc Net Worth (2026) - GuruFocus
Gpg Bfh, Llc Net Worth (2026) - GuruFocus
Gpg Jct, Llc Net Worth (2026) - GuruFocus
Htx Mct3 0322 Investment, Llc Net Worth (2026) - GuruFocus
Htx Mct4 0226 Investment, Llc Net Worth (2026) - GuruFocus
Htx Mct1 0320 Investment, Llc Net Worth (2026) - GuruFocus
Gpg Rm Investment, Llc Net Worth (2026) - GuruFocus
MedTech firm Mobia Medical prices $150M IPO - MSN
Mobia Medical, Inc. (MOBI) grants new stock option awards to director - Stock Titan
Mobia Medical (MOBI) director Reza Zadno files initial Form 3 - Stock Titan
Goldman Sachs Maintains Mobia Medical(MOBI.US) With Buy Rating, Maintains Target Price $31 - Moomoo
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors - Sahm
Mobia Medical appoints Reza Zadno to board of directors By Investing.com - Investing.com Nigeria
Mobia Medical appoints Reza Zadno to board of directors - Investing.com
Mobia Medical (MOBI) names ex-PROCEPT CEO Reza Zadno as director - Stock Titan
Mobia Medical, Inc. Announces Appointment of Reza Zadno as Independent Director and Member of Compensation Committee, Effective July 14, 2026 - marketscreener.com
Mobia Medical (MOBI) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Mobia Medical reports two-year stroke therapy data in Neurology By Investing.com - Investing.com South Africa
Mobia Medical publishes two-year follow-up data from VNS-REHAB study - TipRanks
Mobia Medical reports two-year stroke therapy data in Neurology - Investing.com
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy - The Malone Telegram
Study finds stroke survivors kept movement and daily-life gains for 2 years - Stock Titan
Price to sales forward of Mobia Medical, Inc. – BOATS:MOBI - TradingView
Mobia Medical confirms durable stroke recovery in VNS-REHAB - scanx.trade
Micro Ti Investment, Llc Net Worth (2026) - GuruFocus
Gpg Healthcare Opportunities Fund Ii, Llc Net Worth (2026) - GuruFocus
Htx Mct2 0221 Investment, Llc Net Worth (2026) - GuruFocus
Micro Ti Investment 2, Llc Net Worth (2026) - GuruFocus
Gpg Phl, Llc Net Worth (2026) - GuruFocus
Mti 2015 Investment, Llc Net Worth (2026) - GuruFocus
Mti 20 Investment, Llc Net Worth (2026) - GuruFocus
Price to earnings forward of Mobia Medical, Inc. – NASDAQ:MOBI - TradingView
Enterprise value to EBIT forward of Mobia Medical, Inc. – NASDAQ:MOBI - TradingView
Mobia Medical (MOBI) Revenue BreakdownMain Composition - Moomoo
MOBI SEC FilingsMobia Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Mobia Medical prices IPO at $15 per share, targets $150m - Investing.com
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule - Sahm
CMS proposes to maintain Vivistim procedure payment rate at $45,000 - Investing.com
Mobia Medical Inc Stock (MOBI) Financials Data
There is no financial data for Mobia Medical Inc (MOBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):